Wyeth Spent $876K In 1Q Lobbying On Health Issues

WASHINGTON (AP) — Wyeth, which makes the popular antidepressant Effexor and the blockbuster children's vaccine Prevnar, spent $876,339 in the first quarter lobbying on health care reform and dozens of other issues, according to a recent disclosure form.

That was about 26 percent more than the company spent on lobbying in the first quarter of 2008.

Madison, N.J.-based Wyeth lobbied on several aspects of health care reform, including bills that could limit the prices the government pays for medications, as well as public disclosure of drugmaker payments to doctors. It lobbied on drug advertising rules and legislation to modernize the Food and Drug Administration. ...